Employing nano-enabled artificial intelligence (AI)-based smart technologies for prediction, screening, and detection of cancer
Cancer has been classified as a diverse illness with a wide range of subgroups. Its early
identification and prognosis, which have become a requirement of cancer research, are …
identification and prognosis, which have become a requirement of cancer research, are …
Machine learning for lung cancer diagnosis, treatment, and prognosis
The recent development of imaging and sequencing technologies enables systematic
advances in the clinical study of lung cancer. Meanwhile, the human mind is limited in …
advances in the clinical study of lung cancer. Meanwhile, the human mind is limited in …
An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic
Aim Decreased cancer incidence and reported changes to clinical management indicate
that the COVID‐19 pandemic has delayed cancer diagnosis and treatment. This study aimed …
that the COVID‐19 pandemic has delayed cancer diagnosis and treatment. This study aimed …
Cost-effectiveness analysis of lung cancer screening in the United States: a comparative modeling study
Background: Recommendations vary regarding the maximum age at which to stop lung
cancer screening: 80 years according to the US Preventive Services Task Force (USPSTF) …
cancer screening: 80 years according to the US Preventive Services Task Force (USPSTF) …
Cost-effectiveness evaluation of the 2021 US Preventive Services Task Force recommendation for lung cancer screening
Importance The US Preventive Services Task Force (USPSTF) issued its 2021
recommendation on lung cancer screening, which lowered the starting age for screening …
recommendation on lung cancer screening, which lowered the starting age for screening …
Risk model–based lung cancer screening: a cost-effectiveness analysis
Background: In their 2021 lung cancer screening recommendation update, the US
Preventive Services Task Force (USPSTF) evaluated strategies that select people based on …
Preventive Services Task Force (USPSTF) evaluated strategies that select people based on …
Association between age and survival trends in advanced non–small cell lung cancer after adoption of immunotherapy
T Voruganti, PR Soulos, R Mamtani, CJ Presley… - JAMA …, 2023 - jamanetwork.com
Importance The introduction of immune checkpoint inhibitors (ICIs) has transformed the care
of advanced non–small cell lung cancer (NSCLC). Although clinical trials suggest …
of advanced non–small cell lung cancer (NSCLC). Although clinical trials suggest …
Cost-effectiveness of smoking cessation interventions in the lung cancer screening setting: a simulation study
Background Guidelines recommend offering cessation interventions to smokers eligible for
lung cancer screening, but there is little data comparing specific cessation approaches in …
lung cancer screening, but there is little data comparing specific cessation approaches in …
Racial/ethnic disparities in colorectal cancer treatment utilization and phase-specific costs, 2000-2014
Background Our study analyzed disparities in utilization and phase-specific costs of care
among older colorectal cancer patients in the United States. We also estimated the phase …
among older colorectal cancer patients in the United States. We also estimated the phase …
Cost-effectiveness of pembrolizumab plus axitinib vs nivolumab plus ipilimumab as first-line treatment of advanced renal cell carcinoma in the US
TR Watson, X Gao, KL Reynolds… - JAMA Network Open, 2020 - jamanetwork.com
Importance Checkpoint inhibitor combination therapy represents a major advance in the first-
line treatment of advanced renal cell carcinoma. Pembrolizumab-axitinib and nivolumab …
line treatment of advanced renal cell carcinoma. Pembrolizumab-axitinib and nivolumab …